Literature DB >> 1348603

Preliminary efficacy trial of Cymelarsan, a novel trypanocide, in camels naturally infected with Trypanosoma evansi in Kenya.

M Otsyula1, K Kamar, M Mutugi, A R Njogu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1348603     DOI： 10.1016/0001-706x(92)90084-b

Source DB:  PubMed          Journal:  Acta Trop        ISSN： 0001-706X            Impact factor:   3.112


× No keyword cloud information.
  4 in total

1.  Effect of stage of infection with Trypanosoma evansi on Cymelarsan therapy.

Authors:  R K Biswas; A G Hunter
Journal:  Trop Anim Health Prod       Date:  1993-11       Impact factor: 1.559

2.  Contribution of dithiol ligands to in vitro and in vivo trypanocidal activities of dithiaarsanes and investigation of ligand exchange in an aqueous solution.

Authors:  P M Loiseau; P Lubert; J G Wolf
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

3.  Properties of melarsamine hydrochloride (Cymelarsan) in aqueous solution.

Authors:  B J Berger; A H Fairlamb
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

4.  Systematic review and meta-analysis on the global distribution, host range, and prevalence of Trypanosoma evansi.

Authors:  Weldegebrial G Aregawi; Getahun E Agga; Reta D Abdi; Philippe Büscher
Journal:  Parasit Vectors       Date:  2019-01-31       Impact factor: 3.876
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.